Next Article in Journal
JaPaFi: A Novel Program for the Identification of Highly Conserved DNA Sequences
Next Article in Special Issue
Gene Therapy with Helper-Dependent Adenoviral Vectors: Current Advances and Future Perspectives
Previous Article in Journal
A Hypothesis for Bacteriophage DNA Packaging Motors
Previous Article in Special Issue
Adenoviral Producer Cells
Viruses 2010, 2(9), 1844-1866; doi:10.3390/v2091844

Increasing the Efficacy of Oncolytic Adenovirus Vectors

*  and
Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, 1100 S. Grand Blvd, St. Louis, MO 63104, USA
* Author to whom correspondence should be addressed.
Received: 23 July 2010 / Revised: 17 August 2010 / Accepted: 25 August 2010 / Published: 27 August 2010
(This article belongs to the Special Issue Adenoviral Vectors)
Download PDF [318 KB, uploaded 12 May 2015]


Oncolytic adenovirus (Ad) vectors present a new modality to treat cancer. These vectors attack tumors via replicating in and killing cancer cells. Upon completion of the vector replication cycle, the infected tumor cell lyses and releases progeny virions that are capable of infecting neighboring tumor cells. Repeated cycles of vector replication and cell lysis can destroy the tumor. Numerous Ad vectors have been generated and tested, some of them reaching human clinical trials. In 2005, the first oncolytic Ad was approved for the treatment of head-and-neck cancer by the Chinese FDA. Oncolytic Ads have been proven to be safe, with no serious adverse effects reported even when high doses of the vector were injected intravenously. The vectors demonstrated modest anti-tumor effect when applied as a single agent; their efficacy improved when they were combined with another modality. The efficacy of oncolytic Ads can be improved using various approaches, including vector design, delivery techniques, and ancillary treatment, which will be discussed in this review.
Keywords: adenovirus; replication competent; tumor; virotherapy adenovirus; replication competent; tumor; virotherapy
This is an open access article distributed under the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote |
MDPI and ACS Style

Toth, K.; Wold, W.S.M. Increasing the Efficacy of Oncolytic Adenovirus Vectors. Viruses 2010, 2, 1844-1866.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert